FDA approves first prescription-only app for depression
ZDNet -

Plenty of therapy and wellness apps on the market aim to close gaps in access to mental healthcare -- including cost, provider availability, and insurance roadblocks. However, since they're only minimally or self-regulated and not required to conduct clinical trials, they can't treat mental health disorders. Prescription digital treatments could change that. On Monday, the FDA approved Rejoyn, a smartphone app designed to treat the symptoms of major depressive disorder. Created by Click...

In related news